Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli.
about
Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertensionCoagulation and the vessel wall in pulmonary embolismElevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injuryIncreased expression and activity of sodium channels in alveolar type II cells of hyperoxic rats.Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guidelineChronic thromboembolic pulmonary hypertension (CTEPH).Splenectomy and chronic thromboembolic pulmonary hypertension.Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients.Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysisChronic exposure to fibrin and fibrinogen differentially regulates intracellular Ca2+ in human pulmonary arterial smooth muscle and endothelial cells.Comparison of gene expression profiles and related pathways in chronic thromboembolic pulmonary hypertension.Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension.Platelets in pulmonary hypertension: a causative role or a simple association?From Acute to Chronic Thromboembolic Disease.Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study
P2860
Q26744048-5EAD586D-B60B-4165-B87C-01F83CC7135DQ27021049-C6EB2A52-01D7-48E2-8219-C5EE5C2137B7Q33595107-BC3B2F13-B812-4136-9C79-5D53AC145C7AQ33978703-FE3D7108-3641-47A4-B1BC-C3C2AA908256Q34425513-4D5C7C33-9CCE-43C9-BDB3-B506ADDE4AB7Q34663285-121DEE8F-5235-4348-8ED2-350D86A5EC45Q35537361-993AAF63-ECC9-4C46-BB33-4EF15C9C24F9Q35960192-78EEACD6-0CBE-45FF-9DFE-D0BA64D89424Q37144505-ABA67B3E-E321-4810-978A-277607F30C40Q37218023-CF8A4330-A18C-4999-AC7B-1B5531F3C1A3Q37496096-1A7092B0-080A-46DB-8BB2-80981918FFB3Q37717701-F4CA89DF-08DE-4EF9-85DE-49F453D93864Q38051350-A647CAB2-6DAC-4E80-A759-5D992F20F3B0Q38826925-A0D0B413-6351-4306-A52B-CA347860550FQ47934955-C471AF47-5653-4EC2-85B2-C219ED54D7DEQ57398894-A6ED54CE-CABB-4F05-A2ED-701F51371684
P2860
Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Parallel analysis of tissue-ty ...... ronic pulmonary thromboemboli.
@en
Parallel analysis of tissue-ty ...... ronic pulmonary thromboemboli.
@nl
type
label
Parallel analysis of tissue-ty ...... ronic pulmonary thromboemboli.
@en
Parallel analysis of tissue-ty ...... ronic pulmonary thromboemboli.
@nl
prefLabel
Parallel analysis of tissue-ty ...... ronic pulmonary thromboemboli.
@en
Parallel analysis of tissue-ty ...... ronic pulmonary thromboemboli.
@nl
P2093
P356
P1433
P1476
Parallel analysis of tissue-ty ...... ronic pulmonary thromboemboli.
@en
P2093
P304
P356
10.1161/01.CIR.90.2.706
P407
P577
1994-08-01T00:00:00Z